Healthcare professionals’ perspectives on commercial milk formula marketing in the UK: a qualitative study

Elaine McNaughton, Lydia Y. Chen, Andrea Smith, Rana ConwayArchives 2024 · DOI

TL;DR

This qualitative study explores how UK healthcare professionals (HCPs) navigate the pervasive influence of commercial milk formula (CMF) marketing. While initiatives like the Baby Friendly Initiative (BFI) have successfully reduced industry contact with midwives and health visitors, the study reveals that formula companies have simply pivoted their tactics toward less-regulated channels, forcing HCPs to spend significant clinical time "debunking" marketing-led misinformation.

What Problem Does This Paper Address?

Despite global and UK health recommendations for six months of exclusive breastfeeding, only about one-third of infants in England are exclusively breastfed by 6–8 weeks. A major driver of this gap is the commercial milk formula (CMF) industry, which in the UK alone represents a £100 million market.

While the "International Code of Marketing of Breast-milk Substitutes" exists to regulate this space, its implementation is often voluntary or partial. Previous research has focused heavily on how marketing affects mothers; this paper addresses the perspective of the "gatekeepers"—the healthcare professionals. The authors sought to understand how HCPs experience industry pressure and how they believe the regulatory landscape should evolve to support informed infant feeding.

Methods

The researchers conducted a qualitative study using reflexive thematic analysis.

  • Participants: 41 UK-based HCPs (including health visitors, midwives, paediatricians, dietitians, and GPs) who regularly work with pregnant women and new mothers.
  • Data Collection: Semi-structured interviews conducted between October 2019 and March 2021. Due to the COVID-19 pandemic, the majority of interviews shifted from in-person to online.
  • Analysis: The team used a critical realist epistemology and contextualist ontology to develop themes both deductively (based on existing theory) and inductively (emerging from the data).

Datasets

As a qualitative study, the "dataset" consists of the anonymized transcripts from the 41 semi-structured interviews. The authors provide a detailed breakdown of participant characteristics (Table 1), including roles, locations, and years of experience, to provide context for the qualitative findings.

Key Insights and Ideas

  • The "Hydra" Effect of Regulation: While BFI accreditation successfully blocked industry access to midwives and health visitors, the CMF industry adapted by targeting "new entry points." Participants noted increased industry contact with GPs, paediatricians, and dietitians—roles often less covered by specific breastfeeding-protection initiatives.
  • The "Debunking Tax": HCPs reported that CMF marketing creates a significant "workload" for them. They frequently have to spend limited clinical time "un-teaching" or "squashing" beliefs instilled by advertisements, such as the idea that "specialist" formulas (for reflux or hunger) are medically necessary when they often target normal infant behavior.
  • Exploiting Regulatory Loopholes: A major "aha moment" in the data was the discussion of "follow-on milk" as a marketing proxy. Because advertising "first milk" (0-6 months) is restricted, companies use nearly identical branding and packaging for "follow-on milk" (6+ months) to maintain brand salience and circumvent the spirit of the law.
  • The Asymmetry of Resources: The paper highlights a stark economic reality: the CMF industry spent over £100 million in the UK in 2023, while the NHS spent just £1.3 million on CMF (often purchased below cost by hospitals). This creates an environment where the industry fills "information gaps" that the public sector lacks the resources to cover.

Key Results

The analysis yielded three core themes:

  1. Industry relationships have changed but not disappeared: BFI has been a shield for some, but industry contact remains high for others, particularly around "specialized" products.
  2. Direct-to-consumer marketing challenges HCPs: Marketing is perceived as intentionally misleading, portraying breastfeeding as "bleak" and formula as an "idyllic" solution to common infant issues like broken sleep.
  3. System changes are needed: There was broad consensus among participants for stricter regulations, including:
  4. Full enactment of the WHO Code into UK law.
  5. Plain, standardized packaging for formula to reduce brand-driven emotional appeals.
  6. Restricting formula sales to pharmacies or via medical advice only.

Limitations and Future Work

  • Selection Bias: Participants were self-selected; those with strong views on breastfeeding or marketing may have been more likely to volunteer.
  • Demographic Detail: The authors acknowledge that more granular data on whether participants worked specifically in BFI-accredited settings would have provided better context.
  • The "Missing" Perspective: The study highlights the difficulty of recruiting individuals actually working within CMF marketing, which remains a "black box" for researchers.
  • Future Work: The authors suggest a need for evidence-based, non-industry-funded information sources, particularly regarding specialist formulas, to fill the vacuum currently occupied by commercial representatives.

Summary updated

Abstract

Reduced contact with CMF representatives was reported by HCPs covered by the BFI but continued or increased contact was seen with other HCPs. HCPs believed CMF marketing impacted women's beliefs about infant feeding and they had to work hard to provide a balanced perspective. HCPs wanted stricter regulation of CMF marketing.
BibTeX
@inproceedings{mcnaughton2024healthcare,
  author = {Elaine McNaughton and Lydia Y. Chen and Andrea Smith and Rana Conway},
  title = {{Healthcare professionals’ perspectives on commercial milk formula marketing in the UK: a qualitative study}},
  booktitle = {Archives},
  year = {2024},
  doi = {10.1136/archdischild-2024-327706},
}
Figure